Rituximab with high-dose methotrexate in primary central nervous system lymphoma

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

(2015) A. Omuro et al.   BLOOD

MATILDE chemotherapy regimen for primary CNS lymphoma: Results at a median follow-up of 12 years

(2014) A. J. M. Ferreri et al.   NEUROLOGY

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

(2014) M. Holdhoff et al.   NEUROLOGY

How I treat CNS lymphomas

(2013) J. L. Rubenstein et al.   BLOOD

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

(2013) Patrick G. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

(2013) James L. Rubenstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab is associated with improved survival for aggressive B cell CNS lymphoma

(2013) G. Gregory et al.   NEURO-ONCOLOGY

Rituximab significantly improves complete response rate in patients with primary CNS lymphoma

(2012) Tobias Birnbaum et al.   JOURNAL OF NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

(2011) Michael Pfreundschuh et al.   LANCET ONCOLOGY

Rituximab monotherapy for patients with recurrent primary CNS lymphoma

(2011) T. T. Batchelor et al.   NEUROLOGY

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

(2010) B. Coiffier et al.   BLOOD

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

(2010) Eckhard Thiel et al.   LANCET ONCOLOGY

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

(2009) H. Ghesquieres et al.   ANNALS OF ONCOLOGY